1 483 172 CLINICAL EFFICACY OF VAMANA KARMA WITH IKSHWAAKU BEEJA YOGA FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF ARTAVA KSHAYA W. S. R TO POLYCYSTIC OVARIAN SYNDROME. BACKGROUND: DUE TO SEDENTARY LIFESTYLE AND STRESS, THE INCIDENCE OF METABOLIC DISORDERS ARE INCREASING DAY BY DAY. AMONG THESE POLYCYSTIC OVARIAN SYNDROME (PCOS) IS AN INTRICATE DISORDER AFFECTING 4%-8% WOMEN IN THEIR REPRODUCTIVE AGE AND RELATED TO OVARIAN DYSFUNCTION CHARACTERIZED BY OBESITY, OLIGOMENORRHEA, ANOVULATION AND HYPERANDROGENISM. IN MODERN SYSTEM OF MEDICINE, THE AVAILABLE ALLOPATHIC REGIMEN HAS ITS OWN LIMITATIONS, SO IT IS NEED OF TIME TO FIND A SAFE AND EFFECTIVE ALTERNATIVE THERAPY FOR SUCH TYPE OF CONDITION. THE MOST COMMON SYMPTOM IN 85%-90% OF PCOS PATIENTS IS OLIGOMENORRHEA WHICH CAN BE CORRELATED TO ARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) IN AYURVEDA. HENCE, IN THE PRESENT CLINICAL STUDY, VAMANA KARMA (THERAPEUTIC VOMITING) WITH IKSHWAAKU SEED FORMULATION FOLLOWED BY SHATAPUSHPADI GHANAVATI WAS PLANNED. AIMS: TO EVALUATE THE EFFICACY OF VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF AARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) W. S. R TO PCOS. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS OF PCOS WERE CLINICALLY DIAGNOSED AND TREATED BY VAMANA KARMA (THERAPEUTIC VOMITING) PROCEDURE WITH IKSHWAAKU SEED FORMULATION. AFTER COMPLETION OF VAMANA KARMA (THERAPEUTIC VOMITING) AND SAMSARJANA KRAMA, (POST THERAPY DIETARY REGIMEN FOR REVIVAL) SHATAPUSHPADI GHANAVATI 2 VATI (EACH 500 MG) TWICE IN A DAY WITH LUKEWARM WATER WAS GIVEN FOR 45 DAYS. AFTER COMPLETION OF 2-MONTH TRIAL, ASSESSMENT OF THERAPY WAS ESTIMATED BY SUBJECTIVE AND OBJECTIVE PARAMETERS. RESULTS: STATISTICALLY EXTREMELY SIGNIFICANT (P < 0.0001) RESULTS WERE FOUND IN MENSTRUAL IRREGULARITIES, OBESITY, AND BODY MASS INDEX. THE SIGNIFICANT RESULT IN REDUCTION OF NONDOMINANT FOLLICLES (P = 0.01 AND 0.03 FOR RIGHT AND LEFT OVARY, RESPECTIVELY), LOWERING THE FASTING BLOOD SUGAR LEVEL (P = 0.02) AND HIRSUTISM (P = 0.03) WAS FOUND. CONCLUSION: VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IS VERY EFFECTIVE IN THE MANAGEMENT OF OBESE PCOS PATIENTS AND INCREASING CHANCES OF CONCEPTION. 2017 2 689 43 EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN PREDIABETIC AND TYPE 2 DIABETES UNDER THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS)-AYUSH INTEGRATION PROJECT. BACKGROUND: TYPE 2 DIABETES IS A LIFESTYLE-RELATED DISORDER THAT AFFECTS AROUND 422 MILLION INDIVIDUALS IN INDIA. INTEGRATION OF AYUSH (AYURVEDA) WITH THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS) WAS CONCEIVED ON PILOT BASIS AT GAYA, BIHAR, TO PROVIDE INTEGRATIVE TREATMENT FOR NON-COMMUNICABLE DISEASE PATIENTS AND TO MANAGE THE BURDEN OF NON-COMMUNICABLE DISEASES IN INDIA. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO ANALYZE THE EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES UNDER NPCDCS-AYUSH INTEGRATION PROJECT. MATERIALS AND METHODS: A MULTI-CENTRIC, OPEN-LABELED, PROSPECTIVE, COMPARATIVE CLINICAL STUDY WAS CONDUCTED AT 17 COMMUNITY HEALTH CENTERS AND 1 DISTRICT HOSPITAL. POPULATION OVER 30 YEARS OF AGE WAS SCREENED AND PREDIABETIC OR TYPE 2 DIABETIC INDIVIDUALS WERE ENROLLED IN TWO COHORTS, I.E., PRE-DIABETIC (COHORT A) AND TYPE 2 DIABETIC (COHORT B). EACH COHORT WAS FURTHER DIVIDED INTO TWO GROUPS: GROUP A1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA AND GROUP A2 WAS GIVEN AYURVEDA MEDICATION IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA. SIMILARLY, GROUP B1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION AND GROUP B2 WAS GIVEN AYURVEDA MEDICATION, I.E., MAMAJJAKA, AMALAKI AND GUDUCHI POWDER IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION. TREATMENT WAS GIVEN FOR 6 MONTHS. DATA WERE ANALYZED THROUGH PAIRED T-TEST. RESULTS: A SIGNIFICANT REDUCTION WAS OBSERVED IN FASTING BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001) AND ALSO IN THE POSTPRANDIAL BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001). FURTHER, IMPROVEMENT IN SUBJECTIVE SYMPTOMS SUCH AS POLYURIA, POLYDIPSIA, POLYPHAGIA, BLURRED VISION AND WEAKNESS WAS FOUND IN ALL THE GROUPS, WHILE NON-HEALING ULCER DOES NOT SHOW ANY IMPROVEMENT. CONCLUSION: THE STUDY REVEALS THAT AYURVEDA INTERVENTION, I.E., MAMAJJAKA CHURNA (1 G), AMALAKI CHURNA (3 G) AND GUDUCHI CHURNA (3 G) TWO TIMES A DAY EFFECTIVELY CONTROLS BLOOD SUGAR LEVEL IN PRE-DIABETIC AND TYPE 2 DIABETIC PATIENTS AND IMPROVES THE DISEASE MANAGEMENT WITH LIFESTYLE MODIFICATION AND YOGASANA AS WELL AS WITH ALLOPATHIC TREATMENT. 2019 3 704 39 EFFECT OF INTEGRATED APPROACH OF YOGA AND NATUROPATHY ON POLYCYSTIC OVARIAN SYNDROME: A CASE STUDY. OWING TO STRESS, SEDENTARY LIFESTYLE AND CHANGES IN DIET PATTERN, THERE IS AN INCREASE IN THE SURGE OF LIFESTYLE AND METABOLIC DISORDERS. POLYCYSTIC OVARIAN SYNDROME (PCOS) AFFECTS 8-13% OF REPRODUCTIVE-AGED WOMEN. PCOS IS CHARACTERISED BY MENSTRUAL IRREGULARITY, HYPERANDROGENISM AND POLYCYSTIC OVARIAN MORPHOLOGY (PCOM). THE EFFICACY OF YOGA AS A THERAPY TO TACKLE THE DIRECT AND INDIRECT CAUSE OF AILMENT IN THE MANAGEMENT OF PCOS IS TO BE DOCUMENTED. THIS IS THE CASE STUDY OF A FEMALE PATIENT AGE 25 YEARS, A DIAGNOSED CASE OF PCOS WAS REGISTERED AT THE AYURVEDA, YOGA, UNANI,SIDDHA,HOMEOPATHY (AYUSH), YOGA OPD, WITH COMPLAINTS OF IRREGULAR MENSTRUATION, TREATED SUCCESSFULLY BY YOGA AND NATUROPATHY (Y AND N), I.E., YOGA, DIET AND LIFESTYLE MODIFICATION. THIS IS EVIDENT FROM THE REDUCTION IN WEIGHT, REGULARISATION OF THE MENSTRUAL CYCLE ALONG WITH MORPHOLOGICAL CHANGES IN THE OVARY AFTER A FOLLOW-UP OF 6 MONTHS. 2022 4 2793 24 YOGA THERAPY FOR FIBROMYALGIA SYNDROME: A CASE REPORT. FIBROMYALGIA IS A RHEUMATOLOGIC SYNDROME LEADING TO INCREASED PAIN SENSITIVITY, SLEEP DISTURBANCE, FATIGUE, STIFFNESS, AND TENDERNESS OF JOINTS, MUSCLES, AND TENDONS DUE TO DYSREGULATION OF NEUROPHYSIOLOGICAL FUNCTIONS. IN THE PRESENT CASE REPORT, A 42-YEAR-OLD, NON-INDIAN, NONSMOKING, NONALCOHOLIC, FEMALE PRESENTED WITH COMPLAINTS OF SEVERE DIFFICULTY IN WALKING, JOINT PAINS, AND GENERALIZED LOSS OF BALANCE OF THE BODY. THE PATIENT WAS AN ESTABLISHED CASE OF FIBROMYALGIA. THE TREATMENT PLAN FOR THE PATIENT INCLUDED 9 MONTHS OF YOGA THERAPY. NO CONCOMITANT ALLOPATHIC MEDICATION WAS GIVEN DURING THIS WHOLE TREATMENT PERIOD. THE PATIENT WAS GIVEN SPECIAL YOGA POSTURES TO IMPROVE FLEXIBILITY AND MOVEMENT OF JOINTS, DAILY 1 HOUR, 6 DAYS/WEEK IN THE MORNING, AND EVENING FOR 9 MONTHS. THE MUSCLE FATIGUE, QUALITY OF LIFE AND SLEEP WAS ASSESSED AT THE BASELINE, 3(RD), 6(TH), AND 9(TH) MONTH. THE RESULT OF PRESENT CASE STUDY DEMONSTRATED REDUCTION IN MUSCLE FATIGUE AND IMPROVEMENT IN QUALITY OF LIFE AND SLEEP. 2020 5 840 44 EFFECT OF YOGA ON POLYCYSTIC OVARIAN SYNDROME: A SYSTEMATIC REVIEW. POLYCYSTIC OVARIAN SYNDROME (PCOS) IS NOT A DISEASE BUT A MERE SYNDROME. MANY RESEARCHERS HAVE STUDIED POLYCYSTIC OVARIAN SYNDROME AND FOUND THAT THERE IS NO PROPER CAUSE OF THAT, IT MAY OCCUR DUE TO HORMONAL IMBALANCE OR STRESS, OR DUE TO A SEDENTARY LIFESTYLE. THE RATE OF POLYCYSTIC OVARIAN SYNDROME IN INDIAN WOMEN HAS BEEN INCREASING RAPIDLY. THE SYMPTOMS INCLUDE ACNE, WEIGHT GAIN, HIRSUTISM, DIFFICULTIES IN FERTILITY, IRREGULAR OR INFREQUENT PERIODS, IMMATURE OVARIAN EGGS THAT DO NOT OVULATE, MULTIPLE CYSTS IN THE OVARY. IF LEFT UNTREATED, IT MAY BECOME THE CAUSE FOR HEART DISEASES, DIABETES, HYPERTENSION, INFERTILITY, AND EVEN CANCER. THERE ARE VARIETIES OF MEDICAL TREATMENTS AVAILABLE TO TREAT POLYCYSTIC OVARIAN SYNDROME BUT THEY HAVE A TEMPORARY EFFECT AND IF TAKEN FOR A LONG TIME THEN IT MAY LEAD TO SERIOUS SIDE EFFECTS. YOGA HAS PROVEN EFFECTS IN REDUCING AND MANAGING THE SYMPTOMS OF POLYCYSTIC OVARIAN SYNDROME MORE EFFECTIVELY ALONG WITH MEDICINE. THIS REVIEW WORK HAS BEEN DESIGNED TO CONSIDER THE AVAILABLE LITERATURE CONCERNING THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF THE POLYCYSTIC OVARIAN SYNDROME. IT INCLUDES SOME RESEARCH PAPERS PUBLISHED BETWEEN 2012 AND 2019. BY PROVIDING YOGIC TREATMENT EFFECT ON SEVERAL PARAMETERS (SUCH AS BLOOD LIPID LEVEL, GLUCOSE METABOLISM, ENDOCRINE PARAMETERS, QUALITY OF LIFE, RESTING CARDIOVASCULAR PARAMETERS, LEVEL OF ANXIETY, DEPRESSION) ON THE WOMAN WITH POLYCYSTIC OVARIAN SYNDROME WERE MEASURED. AFTER THOROUGHLY STUDYING ABOUT 74 RESEARCH PAPERS, 16 ARE FOUND MOST RELEVANT TO BE REVIEWED. THE STUDIES OF THESE PAPERS CONCLUDED THE SUCCESSFUL USE OF DIFFERENT YOGIC LIMBS FOR THE MANAGEMENT OF POLYCYSTIC OVARIAN SYNDROME WITH OR WITHOUT MEDICATIONS. 2021 6 2283 46 THE USE OF INTEGRATIVE THERAPY BASED ON YOGA AND AYURVEDA IN THE TREATMENT OF A HIGH-RISK CASE OF COVID-19/SARS-COV-2 WITH MULTIPLE COMORBIDITIES: A CASE REPORT. BACKGROUND: WE REPORT A HIGH-RISK CASE OF A CORONAVIRUS DISEASE 19 (COVID-19)-POSITIVE PATIENT WITH COMORBIDITIES INCLUDING DIABETES MELLITUS (DM), HYPERTENSION (HTN), HYPOTHYROIDISM AND CHRONIC KIDNEY DISEASE (CKD), TREATED SUCCESSFULLY USING AN INTEGRATIVE THERAPY PLAN BASED ON AYURVEDA AND YOGA, ALONG WITH GOVERNMENT-MANDATED COMPULSORY MODERN WESTERN MEDICINE (MWM) TREATMENT. RECENTLY, SOME EVIDENCE HAS BEEN EMERGING ON THE USE OF AYURVEDA FOR TREATMENT OF COVID-19. THE CLASSICAL TEXTS OF AYURVEDIC MEDICINE SUCH AS CHARAKA SAMHITA AND SUSHRUTA SAMHITA CONTAIN DESCRIPTIONS OF PANDEMICS OF SIMILAR PROPORTIONS AND DESCRIBE THEM AS JANAPADODDHVANSA, MEANING THE DESTRUCTION OF COMMUNITIES, ALONG WITH THEIR CAUSES AND TREATMENT. CASE PRESENTATION: THE CASE REPORTED HEREIN IS A 55-YEAR-OLD MAN FROM DELHI, INDIA, WITH CONFIRMED (TESTED) COVID-19, WHO FIRST TOOK MWM FOR 7 DAYS BEFORE SEEKING INTEGRATIVE THERAPY. THE PATIENT HAS COMORBIDITIES INCLUDING DM, HTN, HYPOTHYROIDISM AND CKD AND HAD DEVELOPED SYMPTOMS INCLUDING FEVER (WHICH WAS RESOLVED BY THE TIME INTEGRATIVE THERAPY WAS STARTED), SORE THROAT, DRY COUGH, BODY ACHES, WEAKNESS, BAD TASTE AND SMELL, AND HEAVINESS IN THE ABDOMEN. BASED ON THE PATIENT'S SYMPTOMS AND COMORBIDITIES, A TREATMENT PLAN INCLUDING AYURVEDIC MEDICINES, YOGA PROTOCOL, DIETARY RECOMMENDATIONS AND LIFESTYLE MODIFICATIONS WAS PRESCRIBED BY A REGISTERED AYURVEDA DOCTOR AND A YOGA CONSULTANT. THE PATIENT STARTED EXPERIENCING IMPROVEMENT IN ALL THE SYMPTOMS WITHIN 2 DAYS AFTER STARTING THE TREATMENT; HE REPORTED APPROXIMATELY [FORMULA: SEE TEXT] RELIEF FROM THE SYMPTOMS AFTER 5 DAYS, AND ALMOST COMPLETE RELIEF WITHIN 9 DAYS. ALSO, THE BLOOD SUGAR LEVELS (BOTH FASTING BLOOD SUGAR [FBS] AND POSTPRANDIAL BLOOD SUGAR [PPBS]) EXHIBITED SIGNIFICANT IMPROVEMENT AFTER 5 DAYS, AND DECREASED TO WITHIN THE NORMAL RANGE WITHIN 12 DAYS. BESIDES RELIEF IN SYMPTOMS, THE PATIENT'S REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR) TEST DONE ON THE 19TH DAY RETURNED NEGATIVE RESULTS. CONCLUSIONS: INTEGRATIVE THERAPY WAS FOUND TO BE EFFECTIVE IN MITIGATING THE SYMPTOMS OF COVID-19 IN THIS PATIENT WITH MULTIPLE COMORBIDITIES. MOREOVER, A SIGNIFICANT IMPROVEMENT IN BLOOD SUGAR LEVELS (NOT UNDER CONTROL WITH MODERN MEDICINE) WAS ALSO ACHIEVED. INTEGRATIVE THERAPY BASED ON THE CLASSICAL TEXTS OF AYURVEDA AND YOGA MAY OFFER A PROMISING AND SCALABLE TREATMENT OPTION FOR COVID-19 PATIENTS. A CASE SERIES OR A SUITABLY DESIGNED RANDOMIZED CONTROLLED TRIAL IS NEEDED TO ASSESS ITS EFFICACY. 2021 7 679 37 EFFECT OF A YOGA PROGRAM ON GLUCOSE METABOLISM AND BLOOD LIPID LEVELS IN ADOLESCENT GIRLS WITH POLYCYSTIC OVARY SYNDROME. OBJECTIVE: TO ASSESS THE EFFICACY OF YOGA THERAPY ON GLUCOSE METABOLISM AND BLOOD LIPID VALUES IN ADOLESCENT GIRLS WITH POLYCYSTIC OVARY SYNDROME (PCOS). METHODS: A PROSPECTIVE, RANDOMIZED, INTERVENTIONAL CONTROLLED TRIAL RECRUITED 90 ADOLESCENTS AGED BETWEEN 15 AND 18 YEARS WHO MET THE ROTTERDAM CRITERIA FOR PCOS. A YOGA GROUP PRACTICED SURYANAMASKARA, ASANAS, PRANAYAMA, AND MEDITATION 1 HOUR PER DAY EACH DAY FOR 12 WEEKS WHILE ANOTHER GROUP PRACTICED CONVENTIONAL PHYSICAL EXERCISES. THE MANN-WHITNEY U TEST WAS USED TO COMPARE SCORE CHANGES BETWEEN THE 2 GROUPS. RESULTS: THE CHANGES IN FASTING INSULIN, FASTING BLOOD GLUCOSE, AND HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE WERE SIGNIFICANTLY DIFFERENT IN THE 2 GROUPS (P<0.05). EXCEPT FOR HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, THE CHANGES IN BLOOD LIPID VALUES WERE ALSO SIGNIFICANTLY DIFFERENT (P<0.05). THE CHANGES IN BODY MASS INDEX, WAIST CIRCUMFERENCE, HIP CIRCUMFERENCE, AND WAIST-TO-HIP RATIO, HOWEVER, WERE NOT SIGNIFICANTLY DIFFERENT (P>0.05). CONCLUSION: YOGA WAS FOUND TO BE MORE EFFECTIVE THAN CONVENTIONAL PHYSICAL EXERCISES IN IMPROVING GLUCOSE, LIPID, AND INSULIN VALUES, INCLUDING INSULIN RESISTANCE VALUES, IN ADOLESCENT GIRLS WITH PCOS INDEPENDENT OF ANTHROPOMETRIC CHANGES. CENTRAL TRIAL REGISTRY OF INDIA NO.: REFCTRI-2008 000291. 2012 8 1374 40 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 9 1453 34 INFLUENCE OF PRANAYAMAS AND YOGA-ASANAS ON SERUM INSULIN, BLOOD GLUCOSE AND LIPID PROFILE IN TYPE 2 DIABETES. A DISTINGUISHABLE FEATURE OF TYPE 2 DIABETES BESIDES HYPERGLYCEMIA AND DERANGED LIPID PROFILE IS AN IMPAIRED INSULIN SECRETION, PERIPHERAL INSULIN RESISTANCE AND OBESITY WHICH HAS BECOME A MAJOR HEALTH CONCERN WORLDWIDE. INDIA WITH AN ESTIMATED 31MILLION DIABETICS IN 2000 AND 79MLLIONS BY THE YR 2030 HAS THE HIGHEST NUMBER OF TYPE 2 DIABETICS IN THE WORLD. IN THIS STUDY, WE AIMED TO SEE IF YOGA-ASANAS AND PRANAYAMAS HAVE ANY INFLUENCE IN MODIFYING CERTAIN BIOCHEMICAL PARAMETERS. SIXTY PATIENTS OF UNCOMPLICATED TYPE 2 DIABETES (AGE 35-60 YRS OF 1-10 YRS DURATION) WERE DIVIDED INTO TWO GROUPS: GROUP 1 (N=30): PERFORMED YOGA ALONG WITH THE CONVENTIONAL HYPOGLYCEMIC MEDICINES AND GROUP 2 (N=30): PATIENTS WHO ONLY RECEIVED CONVENTIONAL MEDICINES. DURATION OF THE STUDY WAS 45 DAYS. BASAL RECORDINGS OF BLOOD GLUCOSE (FASTING AND POST-PRANDIAL), LIPID PROFILE AND SERUM INSULIN WERE TAKEN AT THE TIME OF RECRUITMENT AND THE SECOND READING AFTER FORTY FIVE DAYS. RESULTS SHOWED A SIGNIFICANT IMPROVEMENT IN ALL THE BIOCHEMICAL PARAMETERS IN GROUP 1 WHILE GROUP 2 SHOWED SIGNIFICANT IMPROVEMENT IN ONLY FEW PARAMETERS, THUS SUGGESTING A BENEFICIAL EFFECT OF YOGA REGIMEN ON THESE PARAMETERS IN DIABETIC PATIENTS. 2008 10 1703 37 PARTITIONING OF RADIOLOGICAL, STRESS AND BIOCHEMICAL CHANGES IN PRE-DIABETIC WOMEN SUBJECTED TO DIABETIC YOGA PROTOCOL. BACKGROUND: YOGA IS AN ANCIENT SYSTEM OF WELLNESS WITH ASANA AND PRANAYAMA AS ITS MOST POPULAR AND PROPAGATED MODULES FOR MANAGEMENT OF LIFESTYLE DISORDERS. OBJECTIVES: THE AIM OF THE STUDY WAS TO CHARACTERISE THE LIVER ABNORMALITIES, BIOCHEMICAL CHANGES, AND STRESS LEVELS AFTER YOGA INTERVENTION IN PREDIABETIC FEMALES. MATERIALS AND METHODS: 37 FEMALES WERE RANDOMLY DIVIDED INTO YOGA PRACTISING AND NON-PRACTISING CONTROL GROUPS. THE YOGA PRACTISING GROUP PERFORMED DIABETIC YOGA PROTOCOL (DYP) FOR 3 MONTHS. PARAMETERS INCLUDING SIZE OF LIVER, FATTY INFILTRATION, AND GRADE OF SEVERITY WERE MEASURED USING ULTRASONOGRAPHY ALONG WITH BIOCHEMICAL PARAMETERS AND STRESS LEVELS AT BASELINE AND AFTER YOGA PRACTICE. RESULTS: THE GLYCOSYLATED HEMOGLOBIN (HBA1C) AND GLUCOSE LEVELS WERE FOUND SIGNIFICANTLY REDUCED IN PREDIABETIC (P=0.015) WOMEN AFTER PRACTISING DYP, ALTHOUGH CHOLESTEROL LEVELS INCREASED IN MENOPAUSAL WOMEN. NO ESCALATION OF FATTY LIVER WAS NOTED AMONG WOMEN PRACTISING DYP. CONCLUSION: DYP REDUCED THE HBA1C AND STRESS LEVELS AND THEREFORE, COULD BE A COST-EFFECTIVE TOOL FOR PREVENTING PREDIABETES TO DIABETES PROGRESSION. 2019 11 2530 30 YOGA EFFECTS ON ANTHROPOMETRIC INDICES AND POLYCYSTIC OVARY SYNDROME SYMPTOMS IN WOMEN UNDERGOING INFERTILITY TREATMENT: A RANDOMIZED CONTROLLED CLINICAL TRIAL. THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECTS OF YOGA EXERCISES ON ANTHROPOMETRIC PARAMETER AND CLINICAL SIGN OF PCOS AMONG WOMEN UNDERGOING INFERTILITY TREATMENT. THIS CLINICAL TRIAL STUDY WAS PERFORMED ON 61 WOMEN WITH PCOS WHO HAVE UNDERGONE INFERTILITY TREATMENT AT SAREM HOSPITAL IN TEHRAN, IRAN. THE PATIENTS WERE FIRST SELECTING BASED ON PURPOSEFUL AND THEN RANDOMLY ASSIGNING TO THE INTERVENTION AND CONTROL GROUPS. IN THE INTERVENTION GROUP, YOGA EXERCISES WERE PERFORMED FOR 6 WEEKS AND THE PATIENTS IN THE CONTROL GROUP ONLY RECEIVED ROUTINE CARE. ANTHROPOMETRIC PARAMETERS AND CLINICAL SIGNS WERE PERFORMED AND RECORDED. AFTER THE INTERVENTION, HERE WAS A SIGNIFICANT REDUCTION IN HIRSUTISM, ABDOMINAL CIRCUMFERENCE, AND HIP CIRCUMFERENCE SCORES IN THE INTERVENTION GROUP COMPARED TO THE CONTROL GROUP (P < 0.05). GIVEN THE EFFECTS OF YOGA EXERCISES ON THE IMPROVEMENT OF HIRSUTISM, ABDOMINAL CIRCUMFERENCE, AND HIP CIRCUMFERENCE, IT IS SUGGESTED TO USE YOGA AS A TREATMENT STRATEGY IN WOMEN WITH PCOS. 2021 12 959 27 EFFECTS OF A YOGA INTERVENTION ON LIPID PROFILES OF DIABETES PATIENTS WITH DYSLIPIDEMIA. OBJECTIVE: THE PRESENT STUDY WAS CONDUCTED TO ASSESS THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. METHODS: THIS RANDOMIZED PARALLEL STUDY WAS CARRIED OUT IN MEDICAL COLLEGE TRIVANDRUM, KERALA, INDIA. HUNDRED TYPE 2 DIABETICS WITH DYSLIPIDEMIA WERE RANDOMIZED INTO CONTROL AND YOGA GROUPS. THE CONTROL GROUP WAS PRESCRIBED ORAL HYPOGLYCEMIC DRUGS. THE YOGA GROUP PRACTICED YOGA DAILY FOR 1 H DURATION ALONG WITH ORAL HYPOGLYCEMIC DRUGS FOR 3 MONTHS. THE LIPID PROFILES OF BOTH THE GROUPS WERE COMPARED AT THE START AND AT THE END OF 3 MONTHS. RESULTS: AFTER INTERVENTION WITH YOGA FOR A PERIOD OF 3 MONTHS THE STUDY GROUP SHOWED A DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES AND LDL, WITH AN IMPROVEMENT IN HDL. CONCLUSION: YOGA, BEING A LIFESTYLE INCORPORATING EXERCISE AND STRESS MANAGEMENT TRAINING, TARGETS THE ELEVATED LIPID LEVELS IN PATIENTS WITH DIABETES THROUGH INTEGRATED APPROACHES. 2013 13 867 49 EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY IN CORONARY ARTERY DISEASE PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: LUNG FUNCTIONS ARE FOUND TO BE IMPAIRED IN CORONARY ARTERY DISEASE (CAD), CONGESTIVE HEART FAILURE, LEFT VENTRICULAR DYSFUNCTION, AND AFTER CARDIAC SURGERY. DIFFUSION CAPACITY PROGRESSIVELY WORSENS AS THE SEVERITY OF CAD INCREASES DUE TO REDUCTION IN LUNG TISSUE PARTICIPATING IN GAS EXCHANGE. AIMS AND OBJECTIVES: PRANAYAMA BREATHING EXERCISES AND YOGIC POSTURES MAY PLAY AN IMPRESSIVE ROLE IN IMPROVING CARDIO-RESPIRATORY EFFICIENCY AND FACILITATING GAS DIFFUSION AT THE ALVEOLO-CAPILLARY MEMBRANE. THIS STUDY WAS DONE TO SEE THE EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS PARTICULARLY DIFFUSION CAPACITY IN CAD PATIENTS. MATERIALS AND METHODS: A TOTAL OF 80 STABLE CAD PATIENTS BELOW 65 YEARS OF AGE OF BOTH SEXES WERE SELECTED AND RANDOMIZED INTO TWO GROUPS OF 40 EACH. GROUP I CAD PATIENTS WERE GIVEN YOGA REGIMEN FOR 3 MONTHS WHICH CONSISTED OF YOGIC POSTURES, PRANAYAMA BREATHING EXERCISES, DIETARY MODIFICATION, AND HOLISTIC TEACHING ALONG WITH THEIR CONVENTIONAL MEDICINE WHILE GROUP II CAD PATIENTS WERE PUT ONLY ON CONVENTIONAL MEDICINE. LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY WERE RECORDED THRICE IN BOTH THE GROUPS: 0 DAY AS BASELINE, 22(ND) DAY AND ON 90(TH) DAY BY USING COMPUTERIZED MS MEDISOFT CARDIO-RESPIRATORY INSTRUMENT, HYP'AIR COMPACT MODEL OF CARDIO-RESPIRATORY TESTING MACHINE WAS MANUFACTURED BY P K MORGAN, INDIA. THE RECORDED PARAMETERS WERE STATISTICALLY ANALYZED BY REPEATED MEASURES ANOVA FOLLOWED BY TUKEY'S TEST IN BOTH THE GROUPS. CARDIOVASCULAR PARAMETERS WERE ALSO COMPARED BEFORE AND AFTER INTERVENTION IN BOTH THE GROUPS. RESULTS: STATISTICALLY SIGNIFICANT IMPROVEMENTS WERE SEEN IN SLOW VITAL CAPACITY, FORCED VITAL CAPACITY, PEAK EXPIRATORY FLOW RATE, MAXIMUM VOLUNTARY VENTILATION, AND DIFFUSION FACTOR/ TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE AFTER 3 MONTHS OF YOGA REGIMEN IN GROUP I. FORCED EXPIRATORY VOLUME IN 1(ST) SEC (FEV1), AND FEV1 % ALSO SHOWED A TREND TOWARD IMPROVEMENT ALTHOUGH NOT STATISTICALLY SIGNIFICANT. HR, SBP AND DBP ALSO SHOWED SIGNIFICANT IMPROVEMENT IN GROUP-I PATIENTS WHO FOLLOWED YOGA REGIMEN. CONCLUSIONS: YOGA REGIMEN WAS FOUND TO IMPROVE LUNG FUNCTIONS AND DIFFUSION CAPACITY IN CAD PATIENTS BESIDES IMPROVING CARDIOVASCULAR FUNCTIONS. THUS, IT CAN BE USED AS A COMPLIMENTARY OR ADJUNCT THERAPY ALONG WITH THE CONVENTIONAL MEDICINE FOR THEIR TREATMENT AND REHABILITATION. 2015 14 453 35 CHANGES IN MIDAS, PERCEIVED STRESS, FRONTALIS MUSCLE ACTIVITY AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS USAGE IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA FOLLOWING AYURVEDA AND YOGA COMPARED TO CONTROLS: AN OPEN LABELED NON-RANDOMIZED STUDY. BACKGROUND: THERE HAS BEEN A SIGNIFICANT INCREASE IN THE USE OF COMPLEMENTARY AND INTEGRATIVE MEDICINE TO PROVIDE LONG-TERM HEALING SOLUTIONS IN MIGRAINE HEADACHE PATIENTS. KNOWING THE LIMITATIONS OF CONVENTIONAL MEDICAL APPROACH, THE PRESENT STUDY EVALUATED THE INFLUENCE OF TWO INDIAN TRADITIONAL SYSTEMS OF MEDICINE ON MIGRAINE-RELATED DISABILITY, AUTONOMIC VARIABLES, PERCEIVED STRESS, AND MUSCLE ACTIVITY IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA. METHODS: THIRTY SUBJECTS RECRUITED TO THE AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATION) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [NSAID'S]) FOR 90 DAYS. MIGRAINE DISABILITY ASSESSMENT SCORE, PERCEIVED STRESS, HEART RATE VARIABILITY (HRV), AND SURFACE ELECTROMYOGRAPHY (EMG) OF FRONTALIS MUSCLE WERE MEASURED ON DAY 1, DAY 30, AND DAY 90 IN BOTH GROUPS. RESULTS: SIGNIFICANT REDUCTION IN MIGRAINE DISABILITY AND PERCEIVED STRESS SCORES WERE OBSERVED IN THE AY GROUP. THE LOW-FREQUENCY COMPONENT OF THE HRV DECREASED SIGNIFICANTLY, THE HIGH-FREQUENCY COMPONENT INCREASED AND THEIR RATIO SHOWED IMPROVED SYMPATHOVAGAL BALANCE. THE EMG SHOWED DECREASED ACTIVITY OF THE FRONTALIS MUSCLE IN THE AY GROUP COMPARED TO THE CONTROL GROUP. CONCLUSION: THE INTEGRATIVE APPROACH COMBINING AYURVEDA AND YOGA THERAPY REDUCES MIGRAINE-RELATED DISABILITY, PERCEIVED STRESS, SYMPATHETIC AROUSAL, AND MUSCLE TENSION. 2018 15 625 30 DIABETIC YOGA PROTOCOL IMPROVES GLYCEMIC, ANTHROPOMETRIC AND LIPID LEVELS IN HIGH RISK INDIVIDUALS FOR DIABETES: A RANDOMIZED CONTROLLED TRIAL FROM NORTHERN INDIA. PURPOSE: TO STUDY THE EFFECTIVENESS OF DIABETIC YOGA PROTOCOL (DYP) AGAINST MANAGEMENT OF CARDIOVASCULAR RISK PROFILE IN A HIGH-RISK COMMUNITY FOR DIABETES, FROM CHANDIGARH, INDIA. METHODS: THE STUDY WAS A RANDOMIZED CONTROLLED TRIAL, CONDUCTED AS A SUB STUDY OF THE PAN INDIA TRIAL NIYANTRITA MADHUMEHA BHARATH (NMB). THE COHORT WAS IDENTIFIED THROUGH THE INDIAN DIABETES RISK SCORING (IDRS) (>/= 60) AND A TOTAL OF 184 INDIVIDUALS WERE RANDOMIZED INTO INTERVENTION (N = 91) AND CONTROL GROUPS (N = 93). THE DYP GROUP UNDERWENT THE SPECIFIC DYP TRAINING WHEREAS THE CONTROL GROUP FOLLOWED THEIR DAILY REGIMEN. THE STUDY OUTCOMES INCLUDED CHANGES IN GLYCEMIC AND LIPID PROFILE. ANALYSIS WAS DONE UNDER INTENT-TO-TREAT PRINCIPLE. RESULTS: THE 3 MONTHS DYP PRACTICE SHOWED DIVERSE RESULTS SHOWING GLYCEMIC AND LIPID PROFILE OF THE HIGH RISK INDIVIDUALS. THREE MONTHS OF DYP INTERVENTION WAS FOUND TO SIGNIFICANTLY REDUCE THE LEVELS OF POST-PRANDIAL GLUCOSE LEVELS (P = 0.035) AND LDL-C LEVELS (P = 0.014) AND WAIST CIRCUMFERENCE (P = 0.001). CONCLUSION: THE FINDINGS INDICATE THAT THE DYP INTERVENTION COULD IMPROVE THE METABOLIC STATUS OF THE HIGH-DIABETES-RISK INDIVIDUALS WITH RESPECT TO THEIR GLUCOSE TOLERANCE AND LIPID LEVELS, PARTIALLY EXPLAINED BY THE REDUCTION IN ABDOMINAL OBESITY. THE STUDY HIGHLIGHTS THE POTENTIAL ROLE OF YOGA INTERVENTION IN REAL TIME IMPROVEMENT OF CARDIOVASCULAR PROFILE IN A HIGH DIABETES RISK COHORT. TRIAL REGISTRATION: CTRI, CTRI/2018/03/012804. REGISTERED 01 MARCH 2018-RETROSPECTIVELY REGISTERED, HTTP://WWW.CTRI.NIC.IN/ CTRI/2018/03/012804. 2021 16 1476 33 INTEGRATED YOGA AND NATUROPATHY MODULE IN MANAGEMENT OF METABOLIC SYNDROME: A CASE REPORT. A 50-YEAR-OLD MALE PARTICIPANT WITH SEDENTARY LIFESTYLE, DIAGNOSED WITH METABOLIC SYNDROME (METS) [OBESITY, TYPE-2 DIABETES MELLITUS, HYPERTENSION] AND HYPOTHYROIDISM SINCE 2013, WAS ADMINISTERED INTEGRATED YOGA AND NATUROPATHY (IYN) FOR 6 WEEKS AS A TAILOR MADE INDIVIDUALIZED PROTOCOL AT THE RESIDENTIAL INTEGRATIVE MEDICAL FACILITY IN BANGALORE BETWEEN OCTOBER AND NOVEMBER 2015. THE RESULTS SHOWED REDUCTION IN WEIGHT (97.9 KG TO 74.6 KG), BODY MASS INDEX (BMI) (35.1 KG/M(2) TO 27.86 KG/M(2)), TOTAL CHOLESTEROL (192 MG% TO 145 MG%), TRIGLYCERIDES (153 MG% TO 90 MG%), LOW DENSITY LIPOPROTEIN (LDL) (124 MG% TO 81 MG%), HIGH DENSITY LIPOPROTEIN (HDL) (40 MG% TO 46 MG%), FASTING BLOOD GLUCOSE (110 MG/DL TO 75 MG/DL), POSTPRANDIAL GLUCOSE (267 MG/DL TO 100 MG/DL), GLYCATED HEMOGLOBIN (HBA1C) (7.8%-7.1%), THYROID STIMULATING HORMONE (TSH) (6.90 MUIU/ML TO 3.052 MUIU/ML). FOLLOWING THE INTERVENTION, THE ANTI-HYPERTENSIVE, ORAL HYPOGLYCEMIC, THYROID RAISING AND ANALGESIC MEDICINES WERE NOT REQUIRED TO BE CONTINUED. HIS KNEE PAIN MINIMIZED ON DISCHARGE AS OBSERVED ON A VISUAL ANALOG SCALE. HE HAD AN IMPROVED FEELING OF WELLNESS AND OVERALL FUNCTIONAL HEALTH. ALL HIS PARAMETERS WERE WITHIN NORMAL RANGE AT THE 12-WEEKS FOLLOW-UP, AS HE HAD INCORPORATED THE LIFESTYLE PROGRAM INTO HIS DAILY ROUTINE. THIS CASE REPORT SUGGESTS THAT LIFESTYLE CHANGE BY INTEGRATION OF SPECIFIC NON-DRUG YOGA AND NATUROPATHIC INTERVENTION IS USEFUL IN THE MANAGEMENT OF METS. 2017 17 913 38 EFFECTIVENESS OF LIQUID FASTING WITH YOGA AND NATUROPATHY TREATMENTS IN REDUCING METABOLIC AND CARDIOVASCULAR RISKS IN OBESITY. CONTEXT: OBESITY IS ASSOCIATED WITH CHRONIC DISEASES, INCLUDING METABOLIC SYNDROME AND CARDIOVASCULAR DISEASES (CVDS). FASTING IS COMMONLY EMPLOYED BY OBESE PEOPLE TO REDUCE THEIR WEIGHT. LIKEWISE, YOGA AND NATUROPATHY (YN) THAT INCLUDE LIQUID FASTING (LF) HAVE BEEN SHOWN TO BE BENEFICIAL IN REDUCING WEIGHT FOR PEOPLE WITH METABOLIC DISORDERS. HOWEVER, THE SAFETY OF LF DURING YN TREATMENTS AND ITS EFFECTS ON METABOLIC AND CARDIOVASCULAR RISK FACTORS HAVEN'T YET BEEN REPORTED. OBJECTIVE: THE STUDY INTENDED TO EVALUATE THE SAFETY OF LF DURING YN TREATMENTS AND ITS EFFECTS ON METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PEOPLE WITH OBESITY. DESIGN: A SINGLE-GROUP, PRETEST-AND-POSTTEST DESIGN WAS ADOPTED FOR THE STUDY. SETTING: THE STUDY TOOK PLACE IN A YN HOSPITAL LOCATED IN SOUTH INDIA. PARTICIPANTS: PARTICIPANTS WERE 176 OBESE PEOPLE AGED BETWEEN 18 AND 65 YEARS. INTERVENTION: TOGETHER WITH YN TREATMENTS, ALL PARTICIPANTS UNDERWENT LF USING LIME JUICE WITH JAGGERY, ASH GUARD JUICE, VEGETABLE SOUP, BUTTERMILK, AND KOKUM JUICE FOR A PERIOD OF 5 CONSECUTIVE DAYS. OUTCOME MEASURES: ASSESSMENTS SUCH AS BODY WEIGHT, BODY MASS INDEX (BMI), FAT MASS, LIPID PROFILE, AND BLOOD PRESSURE WERE TAKEN AT BASELINE AND POSTINTERVENTION. RESULTS: PARTICIPANTS SHOWED A SIGNIFICANT REDUCTION IN BODY WEIGHT, BMI, FAT MASS, TRIGLYCERIDES (TG), TOTAL CHOLESTEROL (TC), LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C), VERY-LOW-DENSITY LIPOPROTEIN CHOLESTEROL (VLDL-C), HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C), SYSTOLIC BLOOD PRESSURE (SBP), AND DIASTOLIC BLOOD PRESSURE (DBP). CONCLUSIONS: THE RESULTS SUGGEST THAT LF DURING YN TREATMENT CANBE EFFECTIVE IN REDUCING METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PEOPLE WITH OBESITY. 2021 18 374 41 AYURVEDA BODY-MIND CONSTITUTIONAL TYPES AND ROLE OF YOGA INTERVENTION AMONG TYPE 2 DIABETES MELLITUS POPULATION OF CHANDIGARH AND PANCHKULA REGIONS. BACKGROUND: TYPE 2 DIABETES NEEDS A BETTER UNDERSTANDING OF ETIOLOGICAL FACTORS AND MANAGEMENT STRATEGIES BASED ON LIFESTYLE AND CONSTITUTIONAL FACTORS, GIVEN ITS HIGH ASSOCIATION RATE WITH MANY CARDIOVASCULAR, NEUROLOGICAL DISORDERS, AND COVID-19 INFECTION. PURPOSE: THE PRESENT STUDY WAS UNDERTAKEN TO INVESTIGATE THE EFFECT OF DIABETES-SPECIFIC INTEGRATED YOGA LIFESTYLE PROTOCOL (DYP) ON GLYCEMIC CONTROL AND LIPID PROFILES OF DIABETIC ADULTS. ALONG WITH THE DYP INTERVENTION, THE INDIVIDUALS RESIDING IN CHANDIGARH AND PANCHKULA UNION TERRITORIES IN THE NORTHERN PART OF INDIA WERE ASSESSED FOR AYURVEDA-BASED BODY-MIND CONSTITUTIONAL TYPE. AYURVEDA DESCRIBES BODY-MIND CONSTITUTION AS "PRAKRITI," WHICH HAS BEEN DISCUSSED FROM TWO ANGLES, NAMELY PHYSIOLOGICAL AND PSYCHOLOGICAL AS BODY AND MIND ARE CORRELATED. METHODS: CLUSTER SAMPLING OF WAITLIST CONTROL STUDY SUBJECTS WAS USED AS THE SAMPLING METHOD FOR THE STUDY. A TOTAL OF 1,215 REGISTERED SUBJECTS (81 DIABETIC) RESPONDED IN RANDOMLY SELECTED CLUSTERS IN CHANDIGARH AND PANCHKULA. AYURVEDA PHYSICIANS DID AYURVEDA BODY-MIND CONSTITUTIONAL ASSESSMENT CALLED PRAKRITI ASSESSMENT (PHYSIOLOGICAL BODY-MIND CONSTITUTION ASSESSMENT) IN 35 PARTICIPANTS (23 DIABETIC, 12 PREDIABETIC) AS A PART OF THE STUDY. RESULTS: A GROUP OF 50 SUBJECTS WAS RANDOMLY SELECTED FOR YOGA INTERVENTION OUT OF 81 DIABETES MELLITUS ADULTS, AND 31 SUBJECTS WERE ENROLLED AS WAITLIST CONTROLS. A SIGNIFICANT DECREASE IN THE GLYCOSYLATED HEMOGLOBIN LEVELS FROM 8.49 +/- 1.94% TO 7.97 +/- 2.20% IN THE INTERVENTION GROUP WAS NOTICED. THE LIPID PROFILES OF THE DYP INTERVENTION AND CONTROL GROUPS WERE MONITORED. THREE-MONTH FOLLOW-UP RESULTS OF LIPID PROFILE DIAGNOSTIC TESTS IN INTERVENTION AND CONTROL GROUPS SHOWED A SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS (P < 0.05). MOST DIABETIC AND PREDIABETIC INDIVIDUALS WERE FOUND TO HAVE PITTA DOSHA (PITTA CONTROLS ALL HEAT, METABOLISM, AND TRANSFORMATION IN THE MIND AND BODY) AS DOMINANT CONSTITUTION TYPE. CONCLUSION: THE STUDY RESULTS DEMONSTRATED SIGNIFICANT POSITIVE EFFECTS OF YOGA IN DIABETIC INDIVIDUALS. THIS STUDY HAS INDICATED THE EVIDENCE FOR THE SAFETY AND EFFICACY OF THE VALIDATED DYP FOR COMMUNITY-LEVEL INTERVENTIONS TO PREVENT MALADIES LIKE BRAIN DAMAGE AND STROKE. 2020 19 1128 54 EFFICACY OF VAMANA KARMA WITH IKSHVAKU KSHEERA YOGA IN THE MANAGEMENT OF TAMAKA SHVASA (BRONCHIAL ASTHMA). INTRODUCTION: BRONCHIAL ASTHMA IS A HIGHLY PREVALENT DISEASE, AND IN MOST OF THE ETIOPATHOGENESIS AND SYMPTOMATOLOGY, IT CAN BE CORRELATED WITH TAMAKA SHVASA. IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY.) IS AN ANNUAL HERBACEOUS CLIMBING PLANT WITH A LONG HISTORY OF MEDICINAL USES FOR THE TREATMENT OF VARIOUS AILMENTS INCLUDING JAUNDICE, DIABETES, ULCER, PILES, COLITIS, ASTHMA, INSANITY, HYPERTENSION, CONGESTIVE CARDIAC FAILURE AND SKIN DISORDERS. ITS FRUIT PULP IS USED BOTH AS AN EMETIC AND AS A PURGATIVE. AIMS: TO STUDY THE EFFICACY OF VAMANA KARMA WITH IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY) KSHEERA YOGA. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS FULFILLING THE DIAGNOSTIC CRITERIA FOR BRONCHIAL ASTHMA WERE SELECTED FROM OUTPATIENT AND INPATIENT DEPARTMENT OF PANCHAKARMA DEPARTMENT. THE SIGN AND SYMPTOMS, MAINLY BREATHLESSNESS, COUGH AND RHONCHI WERE GIVEN SCORES DEPENDING ON THEIR SEVERITY. THE PATIENTS WERE ALSO ASSESSED FOR LUNG FUNCTION TEST TO DETERMINE PULMONARY IMPAIRMENT. FOR VAMANA, THEY WERE GIVEN DEEPANA AND PACHANA WITH TRIKATU CHURNA FOR 3 DAYS AND THEN THEY WERE SUBJECTED TO SNEHAPANA WITH LUKEWARM COW'S GHEE. AFTER THE COMPLETION OF SNEHAPANA, THE PATIENT WERE GIVEN ABHYANGA, VASHPA SWEDANA AND DIET WITH PREDOMINANCE OF KAPHA (KAPHA BAHULA AHARA- DIET MIXED WITH MILK OR CURD), WHICH WAS THEN FOLLOWED BY VAMANA WITH IKSHVAKU KSHEERA YOGA AND SAMSARJANA KRAMA. FOLLOW-UP WAS DONE AT AN INTERVAL OF 15 DAYS FOR THREE TIMES AND T SCORES WERE NOTED BEFORE AND AFTER THE TREATMENT. THE SCORES WERE ANALYZED USING WILCOXON SIGNED-RANK TEST FOR SUBJECTIVE PARAMETERS AND STUDENT'S PAIRED T-TEST FOR OBJECTIVE PARAMETERS. RESULTS: THE TRIAL DRUG HAS SHOWN STATISTICALLY HIGHLY SIGNIFICANT REDUCTION IN BREATHLESSNESS, COUGH, RHONCHI, AND SIGNIFICANT CHANGES IN LUNG FUNCTION TESTS. CONCLUSION: THE TEST DRUG PROVED ITS EMETIC EFFECT ON THE PATIENTS OF BRONCHIAL ASTHMA AND THUS RELIEVED THE SYMPTOMS OF THE DISEASE IMMEDIATELY. IT HAS REDUCED FREQUENCY OF EPISODES OF BREATHLESSNESS AND SEVERITY OF SYMPTOMS. 2017 20 685 29 EFFECT OF AN INTEGRATED NATUROPATHY AND YOGA PROGRAM ON LONG-TERM GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE COHORT STUDY. AIM: LIFESTYLE IS AN IMPORTANT RISK FACTOR FOR INCREASING THE PREVALENCE OF DIABETES IN THE INDIAN POPULATION. IN THIS STUDY, WE EVALUATE THE EFFECTS OF NATUROPATHY TREATMENT, SALT-RESTRICTED LOW-CALORIE DIETS, AND YOGA IN LONG-TERM GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. METHODS: IN THIS PROSPECTIVE, LONGITUDINAL, TWO-ARM COHORT STUDY, PATIENTS WITH TYPE 2 DIABETES MELLITUS REFERRED FROM A TERTIARY CARE CENTER UNDERGOING A 3-MONTH RESIDENTIAL NATUROPATHY TREATMENT WERE COMPARED WITH THOSE UNDERGOING ONLY CONVENTIONAL MANAGEMENT ON GLYCEMIC CONTROL. BOTH FASTING AND POSTPRANDIAL BLOOD GLUCOSE (PPBG) LEVELS WERE ASSESSED AT BASELINE, 3 MONTHS FOLLOWING INTERVENTION, AT 6 MONTHS, AND 12 MONTHS FROM THE STUDY START. DATA WERE ANALYZED USING REPEATED-MEASURES ANOVA WITH POST HOC BONFERRONI CORRECTION. RESULTS: NATUROPATHY AND YOGA INTERVENTION SIGNIFICANTLY REDUCED PPBG LEVELS (P < 0.001), GLYCATED HEMOGLOBIN LEVELS (P < 0.001), AND REDUCED REQUIREMENT FOR ANTIDIABETIC MEDICATIONS (P < 0.008) IN THE INTERVENTION GROUP COMPARED TO CONTROLS. THE EFFECTS WERE MORE PROFOUND IMMEDIATELY FOLLOWING INTERVENTION AND LASTED UP TO 6 MONTHS FROM THE START OF THE STUDY. CONCLUSION: THE RESULTS SUGGEST BENEFIT WITH AN INTENSIVE RESIDENTIAL NATUROPATHY-BASED LIFESTYLE INTERVENTION PROGRAM. RANDOMIZED CONTROLLED TRIALS ARE NEEDED TO FURTHER VALIDATE THE FINDINGS. 2020